← Eichor
Condition: Interstitial Lung Disease With Systemic Sclerosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Interstitial Lung Disease With Systemic Sclerosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Relate
Phase 2 · 15 location(s) · aTyr Pharma, Inc. · NCT05892614A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Ass
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT06716606A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, a
Phase 2 · 4 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT06189495Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung
Phase 3 · 1 location(s) · University Hospital, Tours · NCT06549231Connective Tissue Diseases and Lung Manifestations
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04095351Platform Clinical Study for Conquering Scleroderma
Phase 2 · 34 location(s) · Scleroderma Research Foundation, Inc. · NCT06195072Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Phase 3 · 1 location(s) · National Institute of Geriatrics, Rheumatology and Rehabilit · NCT06297096Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06350110Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Phase 2/Phase 3 · 131 location(s) · GlaxoSmithKline · NCT05878717A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Phase 2 · 3 location(s) · Galderma R&D · NCT07047690Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT05345795Western Sweden Systemic Sclerosis Project
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07345052Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05785065Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Phase 2 · 3 location(s) · Paul Szabolcs · NCT03630211Registry of Autoimmune Interstitial Lung Disease
Phase N/A · 1 location(s) · EPIMAR registry · NCT05365009Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Phase N/A · 1 location(s) · Hospital de Granollers · NCT07723872
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.